LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,076,975 | -55.5% | 732,636 | -3.8% | 0.00% | -50.0% |
Q2 2023 | $2,421,001 | +34.7% | 761,321 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,796,718 | -32.0% | 761,321 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $2,641,784 | -52.3% | 761,321 | +0.8% | 0.00% | -50.0% |
Q3 2022 | $5,535,000 | +19.9% | 755,105 | +6.7% | 0.01% | +20.0% |
Q2 2022 | $4,615,000 | +16.5% | 707,665 | -9.8% | 0.01% | +66.7% |
Q1 2022 | $3,963,000 | -29.2% | 784,741 | +8.5% | 0.00% | 0.0% |
Q4 2021 | $5,599,000 | -11.5% | 723,370 | +69.2% | 0.00% | 0.0% |
Q3 2021 | $6,327,000 | +50.5% | 427,483 | +65.2% | 0.00% | +50.0% |
Q2 2021 | $4,204,000 | – | 258,823 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |